Pradaxa Lawsuit Ramps Up
If you or a loved one have experienced a Pradaxa injury, please contact Seeger Weiss LLP by filling out the form to the right or calling us directly at 877.541.3273.
Pradaxa is currently being investigated by the FDA for its role in causing hundreds of cases of bleeding injuries and death in patients. The drug is known as an anticoagulant or “blood thinner” and is used primarily for treatment of a condition called atrial fibrillation.
Since its debut on the market, Pradaxa has been prescribed to hundreds of thousands of patients, but recent reports suggest severe—and sometimes deadly—side effects. If you have suffered a Pradax injury, please seek legal help.
At Seeger Weiss LLP, we have built a strong reputation as a leading plaintiff’s law firm and consistently “rank among the country’s top plaintiffs’ lawyers,” according to The National Law Journal.
Pradaxa Injuries Lead to FDA Investigation
In an article published on August 19th, 2012, USA Today reported that “[the] drug has been under attack by physician groups and patient advocates since 3,781 adverse effects and 542 deaths associated with Pradaxa were reported last year to the Food and Drug Administration.” If you are one of these patients, please call 877.541.3273.
No patient should be subject to unnecessary suffering, so if you have been afflicted by a Pradaxa injury, seek legal help immediately and get compensation through a Pradaxa lawsuit.
Seeger Weiss LLP is investigating allegations by the Justice Department that U.S. airlines may have unlawfully colluded to control the number of available seats on flights in order to drive up ticket [...]July 2, 2015 By: Seeger Weiss LLP read more
Results from a recent data mining study conducted at Houston Methodist and Stanford University, California, showed that patients using proton pump inhibitors face a significantly higher risk for suffering a heart attack [...]June 15, 2015 By: Seeger Weiss LLP read more
Experts at The University of Pittsburgh Medical Center and Ohio State University have called for more research into possible health risks of a potentially toxic chemical, gadolinium, remaining in brain tissue of [...]June 12, 2015 By: Seeger Weiss LLP read more